New Drug May Reverse Type 1

EmaxHealth Health News

By Kathleen Blanchard RN for EmaxHealth.com

Researchers from Massachusetts General Hospital (MGH) Immunobiology Laboratory announce findings from a phase I clinical trial that shows the generic drug BCG (bacillus Calmette-Guerin) transiently reversed type 1 diabetes in humans.

According to Denise Faustman, MD, PhD, director of MGH, “We found that even low doses of BCG could transiently reverse type 1 diabetes in human patients.”

“LIKE” EmaxHealth news on Facebook to receive links to important articles in your Facebook feed!

Support Research

Fund Diabetes research and care at The Diabetes Site for free!

Whizzco